An Antibody Screen of a Plasmodium vivax Antigen Library Identifies Novel Merozoite Proteins Associated with Clinical Protection

PLoS Neglected Tropical Diseases

Volumn 10, Issue 5, 2016, Pages

  França, Camila T ^a,b   Hostetler, Jessica B ^c,d   Sharma, Sumana ^d   White, Michael T ^a,e   Lin, Enmoore ^f   Kiniboro, Benson ^f   Waltmann, Andreea ^a,b   Darcy, Andrew W ^g   Li Wai Suen, Connie S N ^a,b   Siba, Peter ^f   King, Christopher L ^h   Rayner, Julian C ^d   Fairhurst, Rick M ^c   Mueller, Ivo ^a,b,i  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^g Ministry of Health   (Solomon Islands)

^h CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN G; MEROZOITE PROTEIN; MICROORGANISM PROTEIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; PARASITE ANTIGEN; PEPTIDE LIBRARY; PROTOZOAL PROTEIN; PROTOZOON ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE LIBRARY; HUMAN; HUMORAL IMMUNITY; IMMUNOGENICITY; IMMUNOREACTIVITY; MICROSCOPY; MIDDLE AGED; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RISK FACTOR; SCHOOL CHILD; SEROPREVALENCE; SOCIOECONOMICS; ANIMAL; BLOOD; CHEMISTRY; COHORT ANALYSIS; DRUG DEVELOPMENT; FEMALE; GENETICS; HIGH THROUGHPUT SCREENING; IMMUNOLOGY; INFANT; INNATE IMMUNITY; ISOLATION AND PURIFICATION; MALARIA, VIVAX; MELANESIA; MEROZOITE; PAPUA NEW GUINEA; PARASITOLOGY; PEPTIDE LIBRARY; YOUNG ADULT;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BIOMARKERS; CHILD; COHORT STUDIES; DRUG DISCOVERY; FEMALE; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; IMMUNITY, INNATE; INFANT; MALARIA, VIVAX; MELANESIA; MEROZOITES; MIDDLE AGED; PAPUA NEW GUINEA; PEPTIDE LIBRARY; PLASMODIUM VIVAX; PROTOZOAN PROTEINS; YOUNG ADULT;

EID: 84971611904     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0004639     Document Type: Article

References (45)

1. WHOWorld Malaria Report 2015. World Health Organization, Geneva, Switzerland. 2015.
2. Alonso PL, Brown G, Arevalo-Herrera M, Binka F, Chitnis C, Collins F, et al. A research agenda to underpin malaria eradication. PLoS medicine. 2011;8(1):e1000406. doi: 10.1371/journal.pmed.100040621311579; PubMed Central PMCID: PMC3026687.
3. Feachem RG, Phillips AA, Hwang J, Cotter C, Wielgosz B, Greenwood BM, et al. Shrinking the malaria map: progress and prospects. Lancet. 2010;376(9752):1566–78. doi: 10.1016/S0140-6736(10)61270-621035842; PubMed Central PMCID: PMC3044848.
4. Betuela I, Rosanas-Urgell A, Kiniboro B, Stanisic DI, Samol L, de Lazzari E, et al. Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1–5 years of age. The Journal of infectious diseases. 2012;206(11):1771–80. doi: 10.1093/infdis/jis58022966124.
5. Robinson LJ, Wampfler R, Betuela I, Karl S, White MT, Li Wai Suen CS, et al. Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical model. PLoS medicine. 2015;12(10):e1001891. doi: 10.1371/journal.pmed.100189126505753; PubMed Central PMCID: PMCPMC4624431.
6. Mueller I, Galinski MR, Baird JK, Carlton JM, Kochar DK, Alonso PL, et al. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. The Lancet Infectious diseases. 2009;9(9):555–66. 19695492. doi: 10.1016/S1473-3099(09)70177-X
7. Bockarie MJ, Dagoro H, Are insecticide-treated bednets more protective against Plasmodium falciparum than Plasmodium vivax-infected mosquitoes?Malaria journal. 2006;5:15. doi: 10.1186/1475-2875-5-1516504027; PubMed Central PMCID: PMC1388224.
8. Luxemburger C, Perea WA, Delmas G, Pruja C, Pecoul B, Moren A, Permethrin-impregnated bed nets for the prevention of malaria in schoolchildren on the Thai-Burmese border. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1994;88(2):155–9. 8036656.
9. Sinka ME, Bangs MJ, Manguin S, Chareonviriyaphap T, Patil AP, Temperley WH, et al. The dominant Anopheles vectors of human malaria in the Asia-Pacific region: occurrence data, distribution maps and bionomic precis. Parasites & vectors. 2011;4:89. doi: 10.1186/1756-3305-4-8921612587; PubMed Central PMCID: PMC3127851.
10. Baird KJ, Maguire JD, Price RN, Diagnosis and treatment of Plasmodium vivax malaria. Advances in parasitology. 2012;80:203–70. doi: 10.1016/B978-0-12-397900-1.00004–923199489.
11. Llanos-Cuentas A, Lacerda MV, Rueangweerayut R, Krudsood S, Gupta SK, Kochar SK, et al. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study. Lancet. 2014;383(9922):1049–58. doi: 10.1016/S0140-6736(13)62568-424360369.
12. mal ERACGoVA research agenda for malaria eradication: vaccines. PLoS medicine. 2011;8(1):e1000398. doi: 10.1371/journal.pmed.100039821311586; PubMed Central PMCID: PMC3026701.
13. Fowkes FJ, Richards JS, Simpson JA, Beeson JG, The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis. PLoS medicine. 2010;7(1):e1000218. doi: 10.1371/journal.pmed.100021820098724; PubMed Central PMCID: PMC2808214.
14. Halbroth BR, Draper SJ, Recent developments in malaria vaccinology. Advances in parasitology. 2015;88:1–49. doi: 10.1016/bs.apar.2015.03.00125911364.
15. Carlton JM, Adams JH, Silva JC, Bidwell SL, Lorenzi H, Caler E, et al. Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature. 2008;455(7214):757–63. doi: 10.1038/nature0732718843361; PubMed Central PMCID: PMC2651158.
16. Bozdech Z, Mok S, Hu G, Imwong M, Jaidee A, Russell B, et al. The transcriptome of Plasmodium vivax reveals divergence and diversity of transcriptional regulation in malaria parasites. Proceedings of the National Academy of Sciences of the United States of America. 2008;105(42):16290–5. doi: 10.1073/pnas.080740410518852452; PubMed Central PMCID: PMC2571024.
17. Chen JH, Jung JW, Wang Y, Ha KS, Lu F, Lim CS, et al. Immunoproteomics profiling of blood stage Plasmodium vivax infection by high-throughput screening assays. Journal of proteome research. 2010;9(12):6479–89. doi: 10.1021/pr100705g20949973.
18. Lu F, Li J, Wang B, Cheng Y, Kong DH, Cui L, et al. Profiling the humoral immune responses to Plasmodium vivax infection and identification of candidate immunogenic rhoptry-associated membrane antigen (RAMA). J Proteomics. 2014;102:66–82. doi: 10.1016/j.jprot.2014.02.02924607491.
19. Finney OC, Danziger SA, Molina DM, Vignali M, Takagi A, Ji M, et al. Predicting antidisease immunity using proteome arrays and sera from children naturally exposed to malaria. Molecular & cellular proteomics: MCP. 2014;13(10):2646–60. doi: 10.1074/mcp.M113.03663225023128; PubMed Central PMCID: PMC4188993.
20. Cutts JC, Powell R, Agius PA, Beeson JG, Simpson JA, Fowkes FJ, Immunological markers of Plasmodium vivax exposure and immunity: a systematic review and meta-analysis. BMC medicine. 2014;12:150. doi: 10.1186/s12916-014-0150-125199532; PubMed Central PMCID: PMC4172944.
21. Mueller I, Shakri AR, Chitnis CE, Development of vaccines for Plasmodium vivax malaria. Vaccine. 2015;33(52):7489–95. doi: 10.1016/j.vaccine.2015.09.06026428453.
22. Hostetler JB, Sharma S, Bartholdson SJ, Wright GJ, Fairhurst RM, Rayner JC, A Library of Plasmodium vivax Recombinant Merozoite Proteins Reveals New Vaccine Candidates and Protein-Protein Interactions. PLoS Negl Trop Dis. 2015;9(12):e0004264. doi: 10.1371/journal.pntd.000426426701602; PubMed Central PMCID: PMCPMC4689532.
23. Crosnier C, Wanaguru M, McDade B, Osier FH, Marsh K, Rayner JC, et al. A library of functional recombinant cell-surface and secreted P. falciparum merozoite proteins. Molecular & cellular proteomics: MCP. 2013;12(12):3976–86. doi: 10.1074/mcp.O113.02835724043421; PubMed Central PMCID: PMCPMC3861738.
24. Bushell KM, Sollner C, Schuster-Boeckler B, Bateman A, Wright GJ, Large-scale screening for novel low-affinity extracellular protein interactions. Genome Res. 2008;18(4):622–30. doi: 10.1101/gr.718780818296487; PubMed Central PMCID: PMCPMC2279249.
25. Kellar KL, Kalwar RR, Dubois KA, Crouse D, Chafin WD, Kane BE, Multiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatants. Cytometry. 2001;45(1):27–36. 11598944.
26. Waltmann A, Darcy AW, Harris I, Koepfli C, Lodo J, Vahi V, et al. High Rates of Asymptomatic, Sub-microscopic Plasmodium vivax Infection and Disappearing Plasmodium falciparum Malaria in an Area of Low Transmission in Solomon Islands. PLoS neglected tropical diseases. 2015;9(5):e0003758. doi: 10.1371/journal.pntd.000375825996619; PubMed Central PMCID: PMC4440702.
27. Lin E, Kiniboro B, Gray L, Dobbie S, Robinson L, Laumaea A, et al. Differential patterns of infection and disease with P. falciparum and P. vivax in young Papua New Guinean children. PloS one. 2010;5(2):e9047. doi: 10.1371/journal.pone.000904720140220; PubMed Central PMCID: PMC2816213.
28. Mueller I, Schoepflin S, Smith TA, Benton KL, Bretscher MT, Lin E, et al. Force of infection is key to understanding the epidemiology of Plasmodium falciparum malaria in Papua New Guinean children. Proc Natl Acad Sci U S A. 2012;109(25):10030–5. doi: 10.1073/pnas.120084110922665809; PubMed Central PMCID: PMCPMC3382533.
29. Koepfli C, Colborn KL, Kiniboro B, Lin E, Speed TP, Siba PM, et al. A high force of plasmodium vivax blood-stage infection drives the rapid acquisition of immunity in papua new guinean children. PLoS neglected tropical diseases. 2013;7(9):e2403. doi: 10.1371/journal.pntd.000240324040428; PubMed Central PMCID: PMC3764149.
30. Piriou E, Kimmel R, Chelimo K, Middeldorp JM, Odada PS, Ploutz-Snyder R, et al. Serological evidence for long-term Epstein-Barr virus reactivation in children living in a holoendemic malaria region of Kenya. J Med Virol. 2009;81(6):1088–93. doi: 10.1002/jmv.2148519382256; PubMed Central PMCID: PMC3134942.
31. Corran P, Coleman P, Riley E, Drakeley C, Serology: a robust indicator of malaria transmission intensity?Trends in parasitology. 2007;23(12):575–82. doi: 10.1016/j.pt.2007.08.02317988945.
32. Yman V, White MT, Rono J, Arca B, Osier FH, Troye-Blomberg M, et al. Antibody acquisition models: A new tool for serological surveillance of malaria transmission intensity. Sci Rep. 2016;6:19472. doi: 10.1038/srep1947226846726.
33. Giraldo J, Vivas NM, Vila E, Badia A, Assessing the (a)symmetry of concentration-effect curves: empirical versus mechanistic models. Pharmacol Ther. 2002;95(1):21–45. 12163126.
34. Stanisic DI, Javati S, Kiniboro B, Lin E, Jiang J, Singh B, et al. Naturally acquired immune responses to P. vivax merozoite surface protein 3alpha and merozoite surface protein 9 are associated with reduced risk of P. vivax malaria in young Papua New Guinean children. PLoS neglected tropical diseases. 2013;7(11):e2498. doi: 10.1371/journal.pntd.000249824244763; PubMed Central PMCID: PMC3828159.
35. Mueller I, Galinski MR, Tsuboi T, Arevalo-Herrera M, Collins WE, King CL, Natural acquisition of immunity to Plasmodium vivax: epidemiological observations and potential targets. Advances in parasitology. 2013;81:77–131. doi: 10.1016/B978-0-12-407826-0.00003–523384622.
36. Elliott SR, Fowkes FJ, Richards JS, Reiling L, Drew DR, Beeson JG, Research priorities for the development and implementation of serological tools for malaria surveillance. F1000Prime Rep. 2014;6:100. doi: 10.12703/P6-10025580254; PubMed Central PMCID: PMCPMC4229730.
37. Longley RJ, Sattabongkot J, Mueller I, Insights into the naturally acquired immune response to Plasmodium vivax malaria. Parasitology. 2016;143(2):154–70. doi: 10.1017/S003118201500067026864134.
38. Osier FH, Mackinnon MJ, Crosnier C, Fegan G, Kamuyu G, Wanaguru M, et al. New antigens for a multicomponent blood-stage malaria vaccine. Sci Transl Med. 2014;6(247):247ra102. doi: 10.1126/scitranslmed.300870525080477.
39. Richards JS, Arumugam TU, Reiling L, Healer J, Hodder AN, Fowkes FJ, et al. Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development. Journal of immunology. 2013;191(2):795–809. doi: 10.4049/jimmunol.130077823776179; PubMed Central PMCID: PMC3702023.
40. Li J, Ito D, Chen JH, Lu F, Cheng Y, Wang B, et al. Pv12, a 6-Cys antigen of Plasmodium vivax, is localized to the merozoite rhoptry. Parasitol Int. 2012;61(3):443–9. doi: 10.1016/j.parint.2012.02.00822394409.
41. Cheng Y, Lu F, Tsuboi T, Han ET, Characterization of a novel merozoite surface protein of Plasmodium vivax, Pv41. Acta tropica. 2013;126(3):222–8. doi: 10.1016/j.actatropica.2013.03.00223499861.
42. Tonkin ML, Arredondo SA, Loveless BC, Serpa JJ, Makepeace KA, Sundar N, et al. Structural and biochemical characterization of Plasmodium falciparum 12 (Pf12) reveals a unique interdomain organization and the potential for an antiparallel arrangement with Pf41. J Biol Chem. 2013;288(18):12805–17. doi: 10.1074/jbc.M113.45566723511632; PubMed Central PMCID: PMCPMC3642325.
43. van Ooij C, Withers-Martinez C, Ringel A, Cockcroft S, Haldar K, Blackman MJ, Identification of a Plasmodium falciparum phospholipid transfer protein. J Biol Chem. 2013;288(44):31971–83. doi: 10.1074/jbc.M113.47418924043620; PubMed Central PMCID: PMCPMC3814793.
44. Fan YT, Wang Y, Ju C, Zhang T, Xu B, Hu W, et al. Systematic analysis of natural antibody responses to P. falciparum merozoite antigens by protein arrays. Journal of proteomics. 2013;78:148–58. doi: 10.1016/j.jprot.2012.11.02023201113.
45. Aurrecoechea C, Brestelli J, Brunk BP, Dommer J, Fischer S, Gajria B, et al. PlasmoDB: a functional genomic database for malaria parasites. Nucleic Acids Res. 2009;37:D539–43. doi: 10.1093/nar/gkn81418957442